Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 140

1.
2.

Cost-effectiveness analysis of hip fracture prevention with vitamin D supplementation: a Markov micro-simulation model applied to the French population over 65 years old without previous hip fracture.

Zarca K, Durand-Zaleski I, Roux C, Souberbielle JC, Schott AM, Thomas T, Fardellone P, Benhamou CL.

Osteoporos Int. 2014 Jun;25(6):1797-806. doi: 10.1007/s00198-014-2698-1.

PMID:
24691648
3.

Cost-effectiveness of vitamin D supplementation and exercise in preventing injurious falls among older home-dwelling women: findings from an RCT.

Patil R, Kolu P, Raitanen J, Valvanne J, Kannus P, Karinkanta S, Sievänen H, Uusi-Rasi K.

Osteoporos Int. 2016 Jan;27(1):193-201. doi: 10.1007/s00198-015-3240-9.

PMID:
26205890
4.

Cost Effectiveness of Falls and Injury Prevention Strategies for Older Adults Living in Residential Aged Care Facilities.

Church JL, Haas MR, Goodall S.

Pharmacoeconomics. 2015 Dec;33(12):1301-10. doi: 10.1007/s40273-015-0313-8.

PMID:
26242882
5.

Effectiveness and safety of vitamin D in relation to bone health.

Cranney A, Horsley T, O'Donnell S, Weiler H, Puil L, Ooi D, Atkinson S, Ward L, Moher D, Hanley D, Fang M, Yazdi F, Garritty C, Sampson M, Barrowman N, Tsertsvadze A, Mamaladze V.

Evid Rep Technol Assess (Full Rep). 2007 Aug;(158):1-235. Review.

6.

Cost-effectiveness and budget impact of Empirical vitamin D therapy on unintentional falls in older adults in the UK.

Poole CD, Smith J, Davies JS.

BMJ Open. 2015 Sep 29;5(9):e007910. doi: 10.1136/bmjopen-2015-007910.

7.

Prevention of falls and fractures in old people by administration of calcium and vitamin D, randomized clinical trial.

López-Torres Hidalgo J; ANVITAD Group..

BMC Public Health. 2011 Dec 9;11:910. doi: 10.1186/1471-2458-11-910.

8.

Cost-effectiveness of screening and vaccinating Asian and Pacific Islander adults for hepatitis B.

Hutton DW, Tan D, So SK, Brandeau ML.

Ann Intern Med. 2007 Oct 2;147(7):460-9.

PMID:
17909207
9.

Monthly High-Dose Vitamin D Treatment for the Prevention of Functional Decline: A Randomized Clinical Trial.

Bischoff-Ferrari HA, Dawson-Hughes B, Orav EJ, Staehelin HB, Meyer OW, Theiler R, Dick W, Willett WC, Egli A.

JAMA Intern Med. 2016 Feb;176(2):175-83. doi: 10.1001/jamainternmed.2015.7148.

PMID:
26747333
10.

Universal bone densitometry screening combined with alendronate therapy for those diagnosed with osteoporosis is highly cost-effective for elderly women.

Schousboe JT, Ensrud KE, Nyman JA, Melton LJ 3rd, Kane RL.

J Am Geriatr Soc. 2005 Oct;53(10):1697-704.

PMID:
16181168
11.

Cost-effectiveness of vitamin D and calcium supplementation in the treatment of elderly women and men with osteoporosis.

Hiligsmann M, Ben Sedrine W, Bruyère O, Evers SM, Rabenda V, Reginster JY.

Eur J Public Health. 2015 Feb;25(1):20-5. doi: 10.1093/eurpub/cku119.

PMID:
25096255
12.

Screening for proteinuria in US adults: a cost-effectiveness analysis.

Boulware LE, Jaar BG, Tarver-Carr ME, Brancati FL, Powe NR.

JAMA. 2003 Dec 17;290(23):3101-14.

PMID:
14679273
13.

Screening for type 2 diabetes mellitus: a cost-effectiveness analysis.

Hoerger TJ, Harris R, Hicks KA, Donahue K, Sorensen S, Engelgau M.

Ann Intern Med. 2004 May 4;140(9):689-99.

PMID:
15126252
14.

Evidence to inform decision makers in Thailand: a cost-effectiveness analysis of screening and treatment strategies for postmenopausal osteoporosis.

Kingkaew P, Maleewong U, Ngarmukos C, Teerawattananon Y.

Value Health. 2012 Jan-Feb;15(1 Suppl):S20-8. doi: 10.1016/j.jval.2011.11.015.

15.

Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting.

Manser R, Dalton A, Carter R, Byrnes G, Elwood M, Campbell DA.

Lung Cancer. 2005 May;48(2):171-85.

PMID:
15829317
16.

The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men.

Goldie SJ, Kuntz KM, Weinstein MC, Freedberg KA, Welton ML, Palefsky JM.

JAMA. 1999 May 19;281(19):1822-9.

PMID:
10340370
17.

Sedative-hypnotic medicines and falls in community-dwelling older adults: a cost-effectiveness (decision-tree) analysis from a US Medicare perspective.

Tannenbaum C, Diaby V, Singh D, Perreault S, Luc M, Vasiliadis HM.

Drugs Aging. 2015 Apr;32(4):305-14. doi: 10.1007/s40266-015-0251-3.

PMID:
25825121
18.

Retrospective cost-effectiveness analysis of screening mammography.

Stout NK, Rosenberg MA, Trentham-Dietz A, Smith MA, Robinson SM, Fryback DG.

J Natl Cancer Inst. 2006 Jun 7;98(11):774-82.

PMID:
16757702
19.

Screening for mild thyroid failure at the periodic health examination: a decision and cost-effectiveness analysis.

Danese MD, Powe NR, Sawin CT, Ladenson PW.

JAMA. 1996 Jul 24-31;276(4):285-92.

PMID:
8656540
20.

Can hip protector use cost-effectively prevent fractures in community-dwelling geriatric populations?

Honkanen LA, Mushlin AI, Lachs M, Schackman BR.

J Am Geriatr Soc. 2006 Nov;54(11):1658-65.

PMID:
17087691

Supplemental Content

Support Center